MedTrace Logo

Effects of WB-EMS in Runners.

NCT03425981 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2018-02-08

No results posted yet for this study

Summary

The subjects will be randomly distributed into 3 experimental groups: training with basic global electrostimulation (WB-EMS-SRT), training with specific global electrostimulation for runners (WB-EMS-WT) and control group (CG).

Initially and at the end of the intervention period, which will consist of six weeks, the subjects will undergo a series of tests: (1) Maximum incremental effort test in tapestry to exhaustion to determine cardiorespiratory capacity (VO2max) and thresholds (aerobic and anaerobic). (2) Submaximal carpet test at constant speed to determine race economy (EC). (3) Lower train power test (CMJ and Abalakov). (4) Weight, size and waist circumference. The aforementioned tests will be carried out on different days to avoid the effect of fatigue on performance with a break of more than 48 hours between tests.

The participants in the control group will maintain the volume and intensity of the training prior to the intervention study and the subjects of the WB-EMS and WB-EMS-AC groups will substitute one conventional training day for one with global electrostimulation for six weeks; the training of the first group will be non-specific and that of the second specific for runners and the duration of both will be 20 minutes.

Conditions

  • Physical Activity

Interventions

OTHER

Whole-Body Electromyostimulation Training

The WB-EMS training program consisted of six WB-EMS training sessions (one per week) and six running training sessions (also one per week). This intervention programme followed a within-day undulating periodization model. The training sessions were divided into four parts: warm up (A), strength (B), high intensity interval power training (c), and high intensity interval training (HIIT) (D).

Sponsors & Collaborators

  • Universidad de Granada

    lead OTHER

Principal Investigators

  • Baseline and post Castillo Garzón, University Proffesor · Universidad de Granada

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2017-12-15
Completion
2018-01-15

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03425981 on ClinicalTrials.gov